Macrogenics Inc (MGNX)

4.37 -0.75 (-14.65%) USD  |  NASDAQ  |  May 17, 16:00
4.42 +0.05 (+1.14%) After-Hours: 20:00
More

Macrogenics Research and Development Expense (Quarterly): 46.03M for March 31, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.
Date Value
March 31, 2024 46.03M
December 31, 2023 47.35M
September 30, 2023 30.13M
June 30, 2023 43.23M
March 31, 2023 45.87M
December 31, 2022 45.65M
September 30, 2022 48.19M
June 30, 2022 51.74M
March 31, 2022 61.44M
December 31, 2021 55.85M
September 30, 2021 49.82M
June 30, 2021 55.78M
March 31, 2021 53.12M
December 31, 2020 42.30M
September 30, 2020 44.66M
June 30, 2020 57.35M
March 31, 2020 48.89M
December 31, 2019 51.96M
September 30, 2019 44.85M
June 30, 2019 51.44M
March 31, 2019 47.06M
December 31, 2018 46.92M
September 30, 2018 46.22M
June 30, 2018 52.01M
Date Value
March 31, 2018 45.67M
December 31, 2017 38.99M
September 30, 2017 40.98M
June 30, 2017 34.46M
March 31, 2017 32.80M
December 31, 2016 31.11M
September 30, 2016 30.30M
June 30, 2016 33.34M
March 31, 2016 27.35M
December 31, 2015 30.04M
September 30, 2015 24.10M
June 30, 2015 22.66M
March 31, 2015 21.46M
December 31, 2014 19.65M
September 30, 2014 18.63M
June 30, 2014 17.34M
March 31, 2014 14.57M
December 31, 2013 14.35M
September 30, 2013 11.09M
June 30, 2013 11.05M
March 31, 2013 10.10M
December 31, 2012 8.508M
September 30, 2012 11.97M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

30.13M
Minimum
Sep 2023
61.44M
Maximum
Mar 2022
48.78M
Average
48.54M
Median

Research and Development Expense (Quarterly) Benchmarks

Moderna Inc 1.063B
Allurion Technologies Inc 6.071M
Novavax Inc 92.68M
United Therapeutics Corp 104.10M
MEI Pharma Inc 5.22M